Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TSX junior pharma getting investor attention

Stockhouse Editorial
0 Comments| April 17, 2015
{{labelSign}}  Favorites
{{errorMessage}}
Top Bullboards post:

“VSX junior pharma getting investor attention,’’ writes NyceTrade in an iCO Therapeutics Inc. (TSX: V.ICO, Stock Forum) post.

Top Bullboard:

Miraculins Inc. (TSX: V.MOM, Stock Forum) was the most posted bullboard, and received the highest number of reads.

Top blog:

Blogger thedave2006 notes that Signal360, Slyce Inc. (TSX: V.SLC, Stock Forum) and SnipSnap have struck an exclusive partnership agreement.

{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company

Visionstate Corp.

Visionstate Corp. V.VIS

Visionstate Corp.is a growth-oriented company that invests in the research and development of the Internet of Things, big ... view more »